1. |
Cole PJ.A new look at the pathogenesis,management of persistent bronchial sepsis:a ‘vicious circle’hypothesis and its logical therapeutic connotations.In:Davies RJ,editor.Strategies for the management of chronic bronchial sepsis.Oxford:Medicine Publishing Foundation,1984,1-20.
|
2. |
Barker AF. Bronchiectasis.N Engl J Med,2002,346.:1383-1393.
|
3. |
Pasteur MC, Helliwell SM, Houghton SJ,et al. An investigation into causative factors in patients with bronchiectasis .Am J Respir Crit Care Med,2000,162:1277-1284.
|
4. |
O’Donnell AE, Barker AF, Ilowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.Chest,1998,113:1329-1334.
|
5. |
Bilton D, Henig N, Morrissey B, et al. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest, 2006;130:1503-1510.
|
6. |
Wallace RJ,Glassroth J,Griffith DE,et al.Diagnosi and treatment of disease caused by nontuberculous mycobacteria.Am J Respir Crit Care Med,1997,156(Suppl):1-25.
|
7. |
Stevens DA,Schwartz HJ,Lee JY,et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.N Engl J Med,2000,342:756-762.
|
8. |
Tsang KW,Ho PI,Chan KN,et al. A pilot study of low-dose erythromycin in bronchiectasis.Eur Respir J. 1999;13:361-364.
|
9. |
Rayner CF,Tillotson G,Cole PJ,et al. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother. 1994 Jul;34(1):149-56..
|
10. |
Stockley RA, Hill SL, Morrison HM. Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state.Thorax. 1984 Jun;39(6):414-9.
|
11. |
Hill SL,Burnett D,Hewetson KA,et al. The response of patients with purulent bronchiectasis to antibiotics for four months. Q J Med,1988;66:163-73.
|